Frank Pallone actually said...

"On average, how much more do consumers in the U.S. pay for these sole-source drugs than consumers in other large countries?"

"single-source, brand-name drugs that lack generic competition represent one of the largest categories of drug spending growth in the Medicare Part D program."

"There's a way to make the free market work for consumers."

"But now we have before us a partisan plan that puts politics over progress."